Annual Working Capital
-$12.16 M
-$22.37 M-219.14%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual working capital is -$12.16 million, with the most recent change of -$22.37 million (-219.14%) on December 31, 2023.
- During the last 3 years, NRXP annual working capital has risen by +$31.07 million (+71.86%).
- NRXP annual working capital is now -158.51% below its all-time high of $20.79 million, reached on December 31, 2021.
Performance
NRXP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$16.19 M
+$2.58 M+13.75%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly working capital is -$16.19 million, with the most recent change of +$2.58 million (+13.75%) on September 30, 2024.
- Over the past year, NRXP quarterly working capital has dropped by -$683.00 thousand (-4.40%).
- NRXP quarterly working capital is now -151.13% below its all-time high of $31.67 million, reached on March 31, 2022.
Performance
NRXP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NRXP Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -219.1% | -4.4% |
| 3 y3 years | +71.9% | -196.6% |
| 5 y5 years | +71.9% | - |
NRXP Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -158.5% | at low | -151.1% | +13.8% |
| 5 y | 5-year | -158.5% | +71.9% | -151.1% | +62.5% |
| alltime | all time | -158.5% | +71.9% | -151.1% | +62.5% |
NRx Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$16.19 M(-13.8%) |
| Jun 2024 | - | -$18.77 M(+21.1%) |
| Mar 2024 | - | -$15.51 M(+27.5%) |
| Dec 2023 | -$12.16 M(-219.1%) | -$12.16 M(+95.0%) |
| Sep 2023 | - | -$6.24 M(+120.5%) |
| Jun 2023 | - | -$2.83 M(+818.5%) |
| Mar 2023 | - | -$308.00 K(-103.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $10.21 M(-50.9%) | $10.21 M(-39.1%) |
| Sep 2022 | - | $16.76 M(-33.8%) |
| Jun 2022 | - | $25.33 M(-20.0%) |
| Mar 2022 | - | $31.67 M(+52.3%) |
| Dec 2021 | $20.79 M(-148.1%) | $20.79 M(+132.3%) |
| Sep 2021 | - | $8.95 M(-152.8%) |
| Jun 2021 | - | -$16.94 M(-60.8%) |
| Dec 2020 | -$43.23 M | -$43.23 M |
FAQ
- What is NRx Pharmaceuticals annual working capital?
- What is the all time high annual working capital for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual working capital year-on-year change?
- What is NRx Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly working capital year-on-year change?
What is NRx Pharmaceuticals annual working capital?
The current annual working capital of NRXP is -$12.16 M
What is the all time high annual working capital for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual working capital is $20.79 M
What is NRx Pharmaceuticals annual working capital year-on-year change?
Over the past year, NRXP annual working capital has changed by -$22.37 M (-219.14%)
What is NRx Pharmaceuticals quarterly working capital?
The current quarterly working capital of NRXP is -$16.19 M
What is the all time high quarterly working capital for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly working capital is $31.67 M
What is NRx Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, NRXP quarterly working capital has changed by -$683.00 K (-4.40%)